Division of Neurobiology, Department of Neurology, Medizinische Universitat Innsbruck, Innsbruck, Austria.
Institute of Neuroscience, Medical University of Innsbruck, Innsbruck, Austria.
Neuropathol Appl Neurobiol. 2021 Feb;47(2):268-282. doi: 10.1111/nan.12661. Epub 2020 Sep 17.
Multiple system atrophy (MSA) is a fatal neurodegenerative disease that belongs to the family of α-synucleinopathies. At post mortem examination, intracellular inclusions of misfolded α-synuclein are found in neurons and oligodendrocytes and are considered to play a significant role in the pathogenesis. However, the early steps of the disease process are unknown and difficult to study in tissue derived from end-stage disease.
Induced pluripotent stem cells (iPSCs) were generated from patients' and control skin fibroblasts and differentiated into NCAM-positive neural progenitor cells (NPCs). The mitochondrial morphology and function were assessed by immunocytochemistry and high resolution respirometry. The ability to cope with exogenous oxidative stress was tested by exposure to different doses of luperox. The expression of α-synuclein was studied by immunocytochemistry.
We identified increased tubulation of mitochondria with preserved respiration profile in MSA-derived NPCs. Exposure of these cells to exogenous oxidative stress even at low doses, triggered an excessive generation of reactive oxygen species (ROS) and cleavage of caspase-3. MSA-derived NPCs did not present changed levels of SNCA gene expression nor intracellular aggregates of α-synuclein. However, we identified disease-related translocation of α-synuclein to the nucleus.
Our results show early cellular dysfunction in MSA-derived NPCs. We identified changes in the redox homeostasis which are functionally compensated at baseline but cause increased susceptibility to exogenous oxidative stress. In addition, nuclear translocation of α-synuclein in MSA-derived NPCs supports an early cellular stress response which may precede the neurodegenerative process in this disorder.
多系统萎缩(MSA)是一种致命的神经退行性疾病,属于α-突触核蛋白病家族。在尸检中,发现神经元和少突胶质细胞中存在错误折叠的α-突触核蛋白的细胞内包涵体,被认为在发病机制中起重要作用。然而,疾病过程的早期步骤尚不清楚,并且难以在源自终末期疾病的组织中进行研究。
从患者和对照皮肤成纤维细胞中生成诱导多能干细胞(iPSC),并将其分化为 NCAM 阳性神经祖细胞(NPC)。通过免疫细胞化学和高分辨率呼吸测量评估线粒体形态和功能。通过暴露于不同剂量的鲁珀罗来测试应对外源性氧化应激的能力。通过免疫细胞化学研究α-突触核蛋白的表达。
我们发现 MSA 来源的 NPC 中线粒体的小管化增加,呼吸特征保持不变。即使在低剂量下,这些细胞暴露于外源性氧化应激中,也会引发过量的活性氧(ROS)产生和半胱天冬酶-3的切割。MSA 来源的 NPC 中没有改变 SNCA 基因表达水平或α-突触核蛋白的细胞内聚集。然而,我们发现α-突触核蛋白在疾病相关的核转位。
我们的研究结果表明 MSA 来源的 NPC 中存在早期细胞功能障碍。我们发现氧化还原稳态发生了变化,这种变化在基线时得到了功能补偿,但会导致对外源性氧化应激的敏感性增加。此外,MSA 来源的 NPC 中α-突触核蛋白的核转位支持早期的细胞应激反应,这可能先于该疾病的神经退行性过程。